The global endomyocardial biopsy market size is calculated at USD 374.41 million in 2024, grew to USD 402.49 million in 2025 and is predicted to surpass around USD 771.67 million by 2034, expanding at a CAGR of 7.50% between 2024 and 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Endomyocardial Biopsy Market
5.1. COVID-19 Landscape: Endomyocardial Biopsy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Endomyocardial Biopsy Market, By Product
8.1. Endomyocardial Biopsy Market Revenue and Volume, by Product, 2024-2034
8.1.1 Forceps
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Accessories
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 9. Global Endomyocardial Biopsy Market, By Tip
9.1. Endomyocardial Biopsy Market Revenue and Volume, by Tip, 2024-2034
9.1.1. Maxi-curved
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Straight
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Pre-curved
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 10. Global Endomyocardial Biopsy Market, By End-use
10.1. Endomyocardial Biopsy Market Revenue and Volume, by End-use, 2024-2034
10.1.1. Hospitals
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Ambulatory Surgical Centers
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 11. Global Endomyocardial Biopsy Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.4.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.1.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.5.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.1.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.2.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.4.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.2.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.5.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.2.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.6.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.2.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.7.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.2.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.3.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.4.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.3.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.5.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.3.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.6.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.3.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.7.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.3.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.4.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.4.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.5.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.4.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.6.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.4.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.7.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.4.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.4.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.5.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.5.2. Market Revenue and Volume Forecast, by Tip (2021-2034)
11.5.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
Chapter 12. Company Profiles
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Boston Scientific Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Medtronic plc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Johnson & Johnson
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Becton, Dickinson and Company
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Cardinal Health, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Teleflex Incorporated
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Terumo Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Argon Medical Devices, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Merit Medical Systems, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample